| Literature DB >> 19210909 |
Maria B Weimer1, Joaquin Wong.
Abstract
Lambert Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disease. Often, the signs and symptoms of LEMS are mistaken for myasthenia gravis and therefore the workup is misdirected. A physician must look for an occult malignancy when the diagnosis is made and then continue to search for a malignancy for at least 5 years after diagnosis. The diagnosis of LEMS can be confirmed with electrophysiologic studies or with serum calcium channel antibodies. In most patients with LEMS, 3,4-diaminopyridine will improve strength. In patients without malignancy, immunosuppressants do have a role in the treatment of LEMS. Patients and physicians must be aware that certain situations and drugs may exacerbate weakness.Entities:
Year: 2009 PMID: 19210909 DOI: 10.1007/s11940-009-0010-z
Source DB: PubMed Journal: Curr Treat Options Neurol ISSN: 1092-8480 Impact factor: 3.598